Date Time
Researchers receive extra support during pandemic
Imperial has distributed £7.8 million additional funding from UK Research and Innovation to protect College research and talent during the pandemic.
The funding was awarded by UK Research and Innovation (UKRI) in spring 2020 to support research projects negatively impacted by the COVID-19 pandemic.
The principles of the funding distribution were developed by the COVID-19 Response Research Group, chaired by Professor Nick Jennings, Vice-Provost for Research and Enterprise, and including the Faculty Vice Deans (Research). It determined that the primary function of the allocated £7.8 million funding should be to protect our research talent. The remaining funds were made available to Departments to use strategically within a prioritisation framework that ensured prioritisation of staff disproportionately affected by the disruption.
ವಿದ್ಯಾರ್ಥಿವೇತನ: ಐಐಟಿ ಗಾಂಧಿನಗರ ಅರ್ಲಿ- ಕೆರಿಯರ್ ಫೆಲೋಶಿಪ್ 2021 prajavani.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prajavani.net Daily Mail and Mail on Sunday newspapers.
Sponsored Sponsored content is premium paid-for content produced by The Irish Times Content Studio on behalf of commercial clients. The Irish Times newsroom or other editorial departments are not involved in the production of Sponsored content.
Industry-academia interface: Enhancing research collaborations
Science Foundation Ireland scheme creates symbiosis between research and workplace
Thu, Apr 29, 2021, 04:00 Sponsored by Science Foundation Ireland
Under the SFI 2021 RD&I Industry Fellowship Programme, the researcher can choose to work with a company for 12 months full-time or 24 months part-time on the collaborative research project.
Applications are now open for Science Foundation Ireland’s 2021 RD&I Industry Fellowship Programme. The programme aims to enhance industry-academia collaboration by funding academic researchers to spend time w
Kahramankart işlemleri 18 noktadan yapılabiliyor marasgundem.com.tr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marasgundem.com.tr Daily Mail and Mail on Sunday newspapers.
Share
A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia.
The clinical trial program (MoST–P), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.
UNSW Dean of Medicine & Health, Professor Vlado Perkovic said the grant could lead to better outcomes for pancreatic cancer patients and more personalised approaches to treatment.
“Our researchers constantly challenge existing knowledge on cancer and are at the forefront of advances in cancer research. The trial announced today is an exciting development in pancreatic cancer research and offers hope for the future for people affected by this terrible disease,” Prof. Perkovic said.